Cargando…
Antibodies Against Phosphorylcholine Among 60-Year-Olds: Clinical Role and Simulated Interactions
AIMS: Antibodies against phosphorylcholine (anti-PC) are implicated as protection markers in atherosclerosis, cardiovascular disease (CVD), and other chronic inflammatory conditions. Mostly, these studies have been focused on IgM. In this study, we determined IgG, IgG1, and IgG2 anti-PC among 60-yea...
Autores principales: | Samal, Shailesh Kumar, Panda, Pritam Kumar, Vikström, Max, Leander, Karin, de Faire, Ulf, Ahuja, Rajeev, Frostegård, Johan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035555/ https://www.ncbi.nlm.nih.gov/pubmed/35479288 http://dx.doi.org/10.3389/fcvm.2022.809007 |
Ejemplares similares
-
Antibodies against malondialdehyde among 60-year-olds: prediction of cardiovascular disease
por: Samal, Shailesh Kumar, et al.
Publicado: (2023) -
Antibodies against Native and Oxidized Cardiolipin and Phosphatidylserine and Phosphorylcholine in Atherosclerosis Development
por: Frostegård, Anna G., et al.
Publicado: (2014) -
IgM antibodies to oxidized phosphatidylserine as protection markers in cardiovascular disease among 60-year olds
por: Frostegård, Johan, et al.
Publicado: (2017) -
Low levels of IgM antibodies to oxidized cardiolipin increase and high levels decrease risk of cardiovascular disease among 60-year olds: a prospective study
por: Su, Jun, et al.
Publicado: (2013) -
Increased prevalence of vulnerable atherosclerotic plaques and low levels of natural IgM antibodies against phosphorylcholine in patients with systemic lupus erythematosus
por: Anania, Cristina, et al.
Publicado: (2010)